Endoscopic Submucosal Injection of Indocyanine Green Before Laparoscopic Gastrectomy
- Conditions
- Endoscopic Submucosal Injection of Indocyanine Green
- Interventions
- Procedure: endoscopic submucosal injection of indocyanine green before laparoscopic gastrectomy
- Registration Number
- NCT04143555
- Lead Sponsor
- Jilin University
- Brief Summary
Prospective registry study of endoscopic submucosal injection of indocyanine green before laparoscopic gastrectomy
- Detailed Description
To observe the imaging result of endoscopic submucosal injection of indocyanine green before laparoscopic gastrectomy, and analyze the relevant factors, so as to guide the operation of preoperative indocyanine green submucosal injection better.
This study is prospective and observational. In order to analyze the related factors that affect the imaging effect, we enrolled patients who were to undergo indocyanine green fluorescence imaging for laparoscopic radical gastrectomy.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 130
- patients who were to undergo indocyanine green fluorescence imaging for laparoscopic radical gastrectomy.
-
have simultaneously other cancer
- have severe systemic inflammatory disease ,serious illness such as diabetes, chronic lung diseases
- have upper gastrointestinal surgery
- Indocyanine green or iodine allergy
- the period is too late or the tumor is too large to carry on a laparoscopy assisted radical distal gastrectomy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description endoscopic submucosal injection of indocyanine green endoscopic submucosal injection of indocyanine green before laparoscopic gastrectomy -
- Primary Outcome Measures
Name Time Method The imaging effect of indocyanine green During the operation The imaging effect was evaluated by indocyanine green fluorescence imaging system during the operation. The effect was divided into grade0 and Grade1. Grade1: The imaging of the tumor and the corresponding lymphatic drainage area in the injection area both were ideal. Grade 0: not up to grade 1, classified into tumor body and drainage area without imaging, only tumor body imaging, and even though tumor body and regional lymph drainage area imaging, the contrast agent in the gastric wall was too diffuse or even overflowing, which seriously interfered with the observation of lymph drainage area imaging.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
the First Hospital of Jilin University
🇨🇳Chang chun, Jilin, China